Loading company…
Shanghai-based medical technology company developing interventional devices for stroke treatment, with four NMPA-approved products.
Based in Shanghai, China and established in 2016, Stroke Care researches and develops interventional medical equipment for stroke treatment, including thrombectomy devices, microcatheters and left atrial appendage occluders. The company has NMPA approval for four ischemic stroke treatment devices. It expected to commercialize nine late-stage product candidates in 2021 and ten earlier-stage candidates between 2022 and 2025. The company is at the late stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in